RACK1 and breast carcinoma: To determine how RACK1 regulates the proliferative capacity of breast cancer cells, we performed a co-immunoprecipitation (IP) assay using anti-Flag antibodies in previously obtained RACK1-flag-expressing MDA-231 cells and analyzed the IP product by mass spectrometry (Fig. 2A).